Reagent substitution in the chromogenic Bethesda assay for factor VIII inhibitors

Podobne zapisy

• Validation of the chromogenic Bethesda assay for factor VIII inhibitors in hemophilia a patients receiving Emicizumab
  od: Miller, Connie H., i wsp.
  Wydane: (2020)
• Reagent substitutions in the Centers for Disease Control and Prevention Nijmegen-Bethesda assay for factor VIII inhibitors
  od: Miller, C. H., i wsp.
  Wydane: (2018)
• Evaluation of pre-analytic heat treatment protocol used in the CDC Nijmegen-Bethesda assay for heat inactivation of extended half-life hemophilia treatment products
  od: Payne, Amanda B., i wsp.
  Wydane: (2019)
• Comparison of Clot-based, Chromogenic, and Fluorescence Assays for Measurement of Factor VIII Inhibitors in the U.S. Hemophilia Inhibitor Research Study
  od: Miller, Connie H., i wsp.
  Wydane: (2013)
• Limit of Detection and Threshold for Positivity of the Centers for Disease Control and Prevention Assay for Factor VIII Inhibitors
  od: Miller, Connie H., i wsp.
  Wydane: (2017)